139 related articles for article (PubMed ID: 9749726)
21. Discriminable excitotoxic effects of ibotenic acid, AMPA, NMDA and quinolinic acid in the rat laterodorsal tegmental nucleus.
Inglis WL; Semba K
Brain Res; 1997 Apr; 755(1):17-27. PubMed ID: 9163537
[TBL] [Abstract][Full Text] [Related]
22. In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis.
Nariai T; DeGeorge JJ; Lamour Y; Rapoport SI
Brain Res; 1991 Sep; 559(1):1-9. PubMed ID: 1723641
[TBL] [Abstract][Full Text] [Related]
23. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional modulation of basal forebrain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance.
Turchi J; Sarter M
Neuroscience; 2001; 104(2):407-17. PubMed ID: 11377844
[TBL] [Abstract][Full Text] [Related]
25. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
26. Age-dependent cerebral metabolic effects of unilateral nucleus basalis magnocellularis ablation in rats.
De Micheli E; Soncrant TT
Neurobiol Aging; 1992; 13(6):687-95. PubMed ID: 1491734
[TBL] [Abstract][Full Text] [Related]
27. A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus.
Soltis RP; Anderson LA; Walters JR; Kelland MD
Brain Res; 1994 Dec; 666(1):21-30. PubMed ID: 7534195
[TBL] [Abstract][Full Text] [Related]
28. Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.
Muir JL; Page KJ; Sirinathsinghji DJ; Robbins TW; Everitt BJ
Behav Brain Res; 1993 Nov; 57(2):123-31. PubMed ID: 7509608
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor antagonists applied to the basal forebrain on cortical acetylcholine release and electroencephalogram desynchronization.
Rasmusson DD; Szerb IC; Jordan JL
Neuroscience; 1996 May; 72(2):419-27. PubMed ID: 8737412
[TBL] [Abstract][Full Text] [Related]
30. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P.
Dermon CR; Tzagournissakis M; Savaki HE
Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349
[TBL] [Abstract][Full Text] [Related]
31. Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia.
Klockgether T; Turski L
Ann Neurol; 1993 Oct; 34(4):585-93. PubMed ID: 7692810
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B.
Wenk GL; Zajaczkowski W; Danysz W
Behav Brain Res; 1997 Feb; 83(1-2):129-33. PubMed ID: 9062671
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of the blood flow response to physostigmine in the rat cortex deafferented from the basal forebrain.
Peruzzi P; Von Euw D; Corrèze JL; Lacombe P
Brain Res Bull; 2007 Apr; 72(1):66-73. PubMed ID: 17303509
[TBL] [Abstract][Full Text] [Related]
34. Administration of either non-NMDA receptor agonists or NMDA receptor antagonists into the substantia nigra or the globus pallidus reduces the psychostimulant effect of high helium pressure on locomotor activity in rats.
Kriem B; Rostain JC; Abraini JH
Neuroreport; 1999 Dec; 10(18):3777-83. PubMed ID: 10716209
[TBL] [Abstract][Full Text] [Related]
35. Receptor function in cortical rat brain regions after lesion of nucleus basalis.
Schliebs R; Feist T; Rossner S; Bigl V
J Neural Transm Suppl; 1994; 44():195-208. PubMed ID: 7897391
[TBL] [Abstract][Full Text] [Related]
36. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
Waters DJ; Allen TG
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
[TBL] [Abstract][Full Text] [Related]
37. Autoradiographic evidence for flow-metabolism uncoupling during stimulation of the nucleus basalis of Meynert in the conscious rat.
Vaucher E; Borredon J; Bonvento G; Seylaz J; Lacombe P
J Cereb Blood Flow Metab; 1997 Jun; 17(6):686-94. PubMed ID: 9236725
[TBL] [Abstract][Full Text] [Related]
38. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis.
Lapchak PA; Araujo DM; Pasinetti G; Hefti F
Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970
[TBL] [Abstract][Full Text] [Related]
39. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.
Hargreaves RJ; Rigby M; Smith D; Hill RG
Br J Pharmacol; 1993 Sep; 110(1):36-42. PubMed ID: 8220897
[TBL] [Abstract][Full Text] [Related]
40. Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.
Jordan GR; McCulloch J; Shahid M; Hill DR; Henry B; Horsburgh K
Neuropharmacology; 2005 Aug; 49(2):254-64. PubMed ID: 15993447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
